Picture of Eramet logo

ERA — Eramet News Story

0.000.00%
fr flag iconLast trade - 00:00
Basic MaterialsSpeculativeMid CapSucker Stock

France's Eramet Q1 turnover rises 13% on higher manganese and nickel ore sales

Overview

France-based mining group's Q1 adjusted turnover rose 13% yr/yr to €840 mln

Growth driven by higher manganese and nickel ore sales, and ramp-up in lithium production

Mineral sands revenue fell 42% after fire at Senegal site; €500 mln capital increase planned for H2

Outlook

Eramet confirms 2026 transported manganese ore target between 6.4 Mt and 6.8 Mt

Company expects 2026 lithium carbonate production between 17 kt-LCE and 20 kt-LCE

Eramet plans €500m capital increase in H2 2026, subject to shareholder approval and market conditions

Result Drivers

MANGANESE AND NICKEL ORE VOLUMES - Higher sales of manganese ore (+10%) and nickel ore (+54%) supported turnover growth, with solid operational performance in Gabon and Indonesia

LITHIUM RAMP-UP - Continued ramp-up in lithium production at Centenario contributed to results, with nameplate capacity close to 80% on average in March

CURRENCY AND COST PRESSURES - Favourable price effects were more than offset by an unfavourable currency effect (-9%) and rising input costs, including energy and freight

Company press release: ID:nGNE9syZb9

Key Details

MetricBeat/MissActualConsensus Estimate
Q1 Adjusted TurnoverEUR 840 mln
Analyst Coverage The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and 2 "sell" or "strong sell" The average consensus recommendation for the diversified mining peer group is "buy." Wall Street's median 12-month price target for Eramet SA is €52.00, about 1.3% below its April 22 closing price of €52.70 For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Eramet

See all news